These findings suggest that ZDHHC19 may serve as a potential biomarker for the diagnosis and prognosis of sepsis and open new avenues for targeted therapeutic interventions aimed at modulating immune responses in this condition. This evidence concerns the gene ZDHHC19 and Sepsis.